BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31758532)

  • 1. Signal Transduction Via Co-stimulatory and Co-inhibitory Receptors.
    Ogawa S; Abe R
    Adv Exp Med Biol; 2019; 1189():85-133. PubMed ID: 31758532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD28-B7 Family of Co-signaling Molecules.
    Nagai S; Azuma M
    Adv Exp Med Biol; 2019; 1189():25-51. PubMed ID: 31758530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphocyte coreceptors].
    Olive D
    Med Sci (Paris); 2006 Dec; 22(12):1069-74. PubMed ID: 17156728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of T cell co-stimulation and co-inhibition.
    Chen L; Flies DB
    Nat Rev Immunol; 2013 Apr; 13(4):227-42. PubMed ID: 23470321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
    Finney HM; Akbar AN; Lawson AD
    J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell co-stimulatory molecules other than CD28.
    Watts TH; DeBenedette MA
    Curr Opin Immunol; 1999 Jun; 11(3):286-93. PubMed ID: 10375549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling.
    Rieder SA; Wang J; White N; Qadri A; Menard C; Stephens G; Karnell JL; Rudd CE; Kolbeck R
    Cell Mol Immunol; 2021 Jun; 18(6):1503-1511. PubMed ID: 32005952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Dynamics of Co-signal Molecules in T-Cell Activation.
    Saito T
    Adv Exp Med Biol; 2019; 1189():135-152. PubMed ID: 31758533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.
    Kagoya Y; Tanaka S; Guo T; Anczurowski M; Wang CH; Saso K; Butler MO; Minden MD; Hirano N
    Nat Med; 2018 Mar; 24(3):352-359. PubMed ID: 29400710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
    Croft M
    Nat Rev Immunol; 2003 Aug; 3(8):609-20. PubMed ID: 12974476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling.
    Latour S
    Biomed J; 2022 Apr; 45(2):321-333. PubMed ID: 35091087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase.
    August A; Dupont B
    Int Immunol; 1994 May; 6(5):769-74. PubMed ID: 8080844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.
    Kim EY; Teh HS
    J Immunol; 2004 Oct; 173(7):4500-9. PubMed ID: 15383581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of human CD28 in murine T cell hybridomas.
    Couez D; Pagès F; Ragueneau M; Nunès J; Klasen S; Mawas C; Truneh A; Olive D
    Mol Immunol; 1994 Jan; 31(1):47-57. PubMed ID: 8302298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86.
    Cefai D; Cai YC; Hu H; Rudd C
    Int Immunol; 1996 Oct; 8(10):1609-16. PubMed ID: 8921441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands.
    Murtaza A; Kuchroo VK; Freeman GJ
    Int Immunol; 1999 Mar; 11(3):407-16. PubMed ID: 10221652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28 ligation induces rapid tyrosine phosphorylation of the linker molecule LAT in the absence of Syk and ZAP-70 tyrosine phosphorylation.
    Tsuchida M; Manthei ER; Knechtle SJ; Hamawy MM
    Eur J Immunol; 1999 Jul; 29(7):2354-9. PubMed ID: 10427998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis.
    Walsh PT; O'Connor R
    Eur J Immunol; 2000 Apr; 30(4):1010-8. PubMed ID: 10760788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression.
    Nikolova M; Marie-Cardine A; Boumsell L; Bensussan A
    Int Immunol; 2002 May; 14(5):445-51. PubMed ID: 11978774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.